Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02322892 · ClinicalTrials.gov registry record · Phase 2
Thiamine as an Adjunctive Therapy in Cardiac Surgery
A Phase 2 study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 64
- Enrollment target
NCT02322892 is a Phase 2 study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 64 participants.
The verdict
NCT02322892, a Phase 2 study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 64 participants
- Enrollment target
Study Summary
The main purpose of this pilot study is to test the effects of thiamine (vitamin B1) administration before and after major cardiac surgery. Half of patients will receive thiamine and the other half will receive placebo. The investigators' main hypothesis is that thiamine will improve cellular oxygen consumption and lead to decreased levels of post-operative lactate levels and ultimately improved patient outcomes.
Interventions
- DRUG Thiamine
- DRUG Normal saline solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02322892
The ClinicalTrials.gov registry entry for NCT02322892 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Thiamine is the first listed.
NCT02322892 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02322892 about?
NCT02322892 is a clinical study titled "Thiamine as an Adjunctive Therapy in Cardiac Surgery". The main purpose of this pilot study is to test the effects of thiamine (vitamin B1) administration before and after major cardiac surgery. Half of patients will receive thiamine and the other half will receive placebo. The investigators' main hypothesis is that thiamine will improve cellular oxyge...
What is the current status of trial NCT02322892?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2015-01. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02322892?
The interventions under investigation include: Thiamine (DRUG), Normal saline solution (DRUG).
Who is sponsoring clinical trial NCT02322892?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.